Article
Effects of Cholesterol Modulation on Cisplatin-Induced Hearing Loss
2025-09-26
Abstract excerpt
<h4>ABSTRACT</h4> Cisplatin is a widely used and effective anticancer drug. However, it causes permanent sensorineural hearing loss in over 50% of treated patients. There are no FDA-approved therapies to prevent cisplatin-induced hearing loss (CIHL) in adults, highlighting a critical unmet clinical need. Previous studies suggest that statins, commonly prescribed cholesterol-lowering drugs, are associated with red...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ecfdc584-3acb-5311-9719-c0661337694c
- DOI
- 10.1101/2025.09.23.678043
